Panic disorder treatment research

The two treatments with the strongest evidence for panic disorder are cognitive behavioral therapy that includes interoceptive exposure, and SSRIs. Head-to-head, meta-analyses don't show one to be reliably superior to the other for short-term symptom reduction. Both work for many patients.

The more interesting research question is about combining and sequencing them. Studies of combined treatment, CBT plus medication, suggest a short-term advantage over either treatment alone, and the advantage is clearest for more severe panic. That advantage narrows over the longer term. Some evidence points to CBT carrying a relapse-protection benefit that medication alone doesn't, because the interoceptive exposure skills remain available to the patient after treatment ends.

Sequencing has been studied directly in panic. Some patients tolerate exposure-based CBT more easily after a partial medication response has taken the edge off the worst symptoms. Others prefer to start with CBT and add medication only if it's needed. The research doesn't name one correct order.

One research direction worth knowing about is the use of CBT to support coming off medication. Stepping medication down while CBT skills consolidate has been studied as a way to capture both the speed of medication and the durability of therapy. The picture is promising but isn't yet settled.

Guidelines from the APA and NICE list CBT with interoceptive exposure and SSRIs as first-line for panic disorder, and they treat combined treatment as a reasonable option for more severe presentations. Benzodiazepines are positioned for short-term use, not long-term monotherapy.